Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.33
BATS BZX Real-Time Price
As of 9:47am ET
 -0.29 / -5.16%
Today’s Change
4.39
Today|||52-Week Range
9.02
-32.53%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close5.62
Today’s open5.39
Day’s range5.33 - 5.52
Volume4,202
Average volume (3 months)2,937,656
Market cap$728.4M
Dividend yield--
Data as of 9:47am ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+2.51%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.55-3.44%
ARDXArdelyx Inc-0.10-0.62%
SCMPSucampo Pharmaceutic...-0.50-3.16%
ITCIIntra-Cellular Thera...-0.42-2.57%
Data as of 9:47am ET, 12/07/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gary L. Crocker
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs